Skip to main content

Table 5 Baseline characteristics and pregnancy outcomes of patients with different stages of blastocyst transferred in the sequential ET group (\(\bar x\) ± s; %)

From: Stratified analysis of clinical pregnancy outcomes of sequential embryo transfer in frozen embryo transfer cycles based on different factors: a retrospective study

Indicators

D5 blastocyst transferred

(n = 216)

D6 blastocyst transferred

(n = 144)

P-value

Age (yr)

31.76 ± 4.52

31.69 ± 4.41

0.874

BMI (kg/m2)

22.77 ± 3.75

22.34 ± 3.19

0.261

Infertility duration (yr)

3.78 ± 2.85

3.69 ± 2.70

0.770

AMH (ng/ml)

5.70 ± 4.90

5.76 ± 4.78

0.901

bFSH (mIU/ml)

6.81 ± 4.13

6.52 ± 3.00

0.463

Number of failed cycles

3.16 ± 1.64

3.33 ± 1.77

0.348

Number of embryos transferred

2.27 ± 0.45

2.31 ± 0.47

0.397

Endometrial thickness (mm)

10.74 ± 2.08

11.06 ± 2.26

0.139

High-quality cleavage-stage embryo rate

43.3 (101/233)

40.4 (76/188)

0.546

Primary infertility rate

59.7 (129/216)

56.9 (82/144)

0.600

Infertility factors

   

Male factors

24.5 (53/216)

22.9 (33/144)

0.724

Tube and pelvic factors

43.1 (93/216)

37.5 (54/144)

0.293

Ovulatory factors

5.6 (12/216)

4.2 (6/144)

0.554

Couples’ factors

19.0 (41/216)

24.3 (35/144)

0.225

Others

7.9 (17/216)

11.1 (16/144)

0.297

Clinical pregnancy rate

33.8 (73/216)

28.5 (41/144)

0.287

Implantation rate

19.6 (97/494)

15.4 (51/332)

0.116

Multiple pregnancy rate

24.7 (18/73)

19.5 (8/41)

0.530

Miscarriage rate

12.3 (9/73)

14.6 (6/41)

0.727

  1. Note: BMI = Body mass index; AMH = anti-Mullerian hormone; bFSH = base follicle stimulating hormone